Today: 3 May 2026
Browse Category

NYSE:CANF 18 November 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma shares surged over 30% Tuesday after reporting a patient with advanced hepatocellular carcinoma remained cancer-free for nine years on its drug Namodenoson. The company also began enrolling patients in a pivotal Phase III trial for the treatment in Israel, Europe, and the U.S. Namodenoson holds Orphan Drug and Fast Track designations.
18 November 2025
···

Stock Market Today

  • XRP Price Forecast by December 2026 from Three AI Models
    May 3, 2026, 12:12 PM EDT. XRP trades near $1.35-$1.40, down 62% from its $3.65 peak in July last year. Three AI models-ChatGPT, Grok, and Google Gemini-offer varying XRP forecasts for December 2026. ChatGPT predicts $0.95 in a bear case, $2.15 base, and $3.35 in a bull scenario. Grok ranges from $0.80-$1.10 bear to $5-$8 bull. Google Gemini's bear target is $1.50, with a bullish peak at $8-$10. Base cases center on steady regulatory progress, ETF inflows, and Bitcoin recovering to $80,000-$90,000. Bullish outcomes depend on significant Bitcoin rallies and higher institutional adoption. Bear cases suggest potential losses or stagnation without catalysts. Overall, AI models see moderate growth likely, while uncertainties around regulation and market forces remain key risks.

Latest article

Cameco Corporation Earnings Countdown: The Uranium Stock Test Investors Are Watching

Cameco Corporation Earnings Countdown: The Uranium Stock Test Investors Are Watching

3 May 2026
Cameco shares closed lower Friday, with NYSE-listed CCJ at $120.60 and TSX-listed CCO at C$163.66. The uranium supplier reports first-quarter results before markets open May 5, followed by an executive call at 8 a.m. Eastern. Investors are watching uranium prices, delivery timing, and Cameco’s 49% stake in Westinghouse. The company’s annual meeting is set for May 7.
Everspin Stock Jumps After $40 Million Defense MRAM Deal — Why Investors Are Watching Now

Everspin Stock Jumps After $40 Million Defense MRAM Deal — Why Investors Are Watching Now

3 May 2026
Everspin Technologies shares jumped $3.19 to $21.49 after announcing a $40 million U.S. defense MRAM subcontract with Amentum Services, set to run through November 2028. First-quarter revenue rose to $14.9 million, with MRAM product sales at $14.1 million. The company posted a GAAP net loss of $0.3 million. Second-quarter revenue is forecast at $15.5 million to $16.5 million.
Why ON Semiconductor’s $103 Stock Faces a Hard Earnings Test on Monday

Why ON Semiconductor’s $103 Stock Faces a Hard Earnings Test on Monday

3 May 2026
ON Semiconductor will report first-quarter earnings after markets close Monday, with analysts expecting 61 cents per share on $1.49 billion in revenue. Shares closed at $103.03 Friday, up 2.2%, far above the average analyst target of $67.15. Investors are focused on signs of recovery in auto and industrial chip demand. The company’s market value stands at about $42 billion.
Go toTop